Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Down 27.1% in November

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 78,800 shares, a drop of 27.1% from the October 31st total of 108,100 shares. Based on an average daily volume of 648,600 shares, the days-to-cover ratio is currently 0.1 days. Currently, 19.4% of the company’s shares are short sold.

Avalon GloboCare Stock Performance

NASDAQ ALBT opened at $2.80 on Friday. The stock’s 50-day moving average price is $3.08 and its two-hundred day moving average price is $4.78. The company has a market cap of $3.06 million, a PE ratio of -0.14 and a beta of 0.31. Avalon GloboCare has a 1 year low of $2.11 and a 1 year high of $21.60.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.